SEL-212 not checked

Swedish Orphan Biovitrum

FollowEvery change as it happens, and a Monday email
Stage
No active trials
 
Next date
None yet
 
Trials
0 active
2 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“IV infusion of SEL-212 high-dose every 28 days for a total of up to 12 infusions”In the company’s words, NCT04513366 on ClinicalTrials.gov
Tested for
Chronic Gout (2 trials)
Main trialPhase 3
“This is one of two replicate randomized, double-blind, placebo-controlled, parallel arm trials to determine the safety and efficacy of two different dose levels of SEL-212 compared to placebo. 112 and 153 patients, stratified as to the presence or absence of tophi, were randomized in a 1:1:1 allocation ratio prior to Baseline to receive treatment with one of two dose levels of SEL-212 or placebo every 28 days for approximately 6 months in each trial respectively (SEL-212/301 and SEL-212/302). Analysis of primary and key efficacy was performed at Day 28 of Treatment Period 6. Safety was…”In the company’s words, NCT04513366 on ClinicalTrials.gov

Other drugs for Chronic Gout

All 12 drugs for Chronic Gout

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials2

TrialPhaseCompletesWhat it tests
Phase 3Completed 21 Jul 2022 A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy
Phase 3Completed 10 Jan 2023 A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy II
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow SEL-212

Following is part of Solo: you see every change to SEL-212 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in